Profil
Scott A.
Young currently works at Flexion Therapeutics, Inc., as VP-Corporate Communications & Investor Relations from 2018 and Invivyd, Inc., as Head-Investor Relations from 2023.
Aktive Positionen von Scott A. Young
| Unternehmen | Position | Beginn |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Investor Relations Contact | 01.11.2016 |
| INVIVYD, INC. | Investor Relations Contact | 01.08.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INVIVYD, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
